BRAF, ERK and p16 in ovarian serous tumorigenesis

被引：0
|
作者：
Schlosshauer, P. W.
Fatemi, D.
Pearl, M.
Deligdisch, L.
Penault-Llorca, F.
Qiao, R.
Shen, H.
Dong, J.
机构：
[1] Mt Sinai Sch Med, New York, NY USA
[2] Cornell Univ, Weill Med Coll, New York, NY USA
[3] Ctr Jean Perrin, Clermont Ferrand, France
[4] Univ Texas Med Branch Galveston, Galveston, TX USA
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1022
引用
收藏
页码：223A / 223A
页数：1
相关论文
共 50 条
  • [31] Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis
    J C Soria
    L Morat
    F Commo
    D Dabit
    S Perie
    L Sabatier
    P Fouret
    British Journal of Cancer, 2001, 84 : 504 - 511
  • [32] p16 loves me, p16 loves me not
    McCalmont, Timothy H.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2012, 39 (12) : 1060 - 1061
  • [33] DIAGNOSTIC SIGNIFICANCE OF P53, P16, WT1 IN LAVAGE SAMPLES FROM UTERINE CAVITY FOR SEROUS OVARIAN CANCER DETECTION
    Zhordania, K.
    Gokadze, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A161 - A161
  • [34] UVR induced ERK signaling pathway regulates p16 expression in skin
    Giles, N.
    Pavey, S.
    Gabrielli, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (12) : 2919 - 2919
  • [35] Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein
    Armes, Jane E.
    Lourie, Rohan
    de Silva, Melanie
    Stamaratis, Georgia
    Boyd, Alison
    Kumar, Beena
    Price, Gareth
    Hyde, Simon
    Allen, David
    Grant, Peter
    Venter, Deon J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (04) : 363 - 368
  • [36] Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population
    Mackiewicz-Wysocka, Malgorzata
    Czerwinska, Patrycja
    Filas, Violetta
    Bogajewska, Elzbieta
    Kubicka, Agata
    Przybyla, Anna
    Dondajewska, Ewelina
    Kolenda, Tomasz
    Marszalek, Andrzej
    Mackiewicz, Andrzej
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2017, 34 (05): : 490 - 498
  • [37] MOLECULAR LANDSCAPE IN HIGH-GRADE SEROUS OVARIAN CANCER: THE CORRELATION BETWEEN BRCA MUTATIONAL STATUS AND STROMAL P16 EXPRESSION
    Caretto, M.
    Pistolesi, S.
    Naccarato, A. G.
    Simoncini, T.
    Gadducci, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A338 - A338
  • [38] Aberrant p16 Expression in Endometrial Serous Carcinoma: A Clinicopathological Study of 142 Cases
    Islam, Sadeq
    Ines, Flora Mae Sta.
    Kowtha, Lakshmi
    Ou, Joyce
    Singh, Kamaljeet
    Hansen, Katrine
    Collins, Victoria
    Sung, C. James
    Quddus, M. Ruhul
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1162 - S1164
  • [39] Expression of p16 tumor suppressor gene in epithelial ovarian cancer
    Li, A
    Dionyssios, K
    Abreo, F
    Fracchioli, S
    Turbat-Herrera, EA
    Singal, R
    Li, B
    Yu, H
    MODERN PATHOLOGY, 2002, 15 (01) : 201A - 202A
  • [40] p16 Overexpression: A Potential Early Indicator of Transformation in Ovarian Carcinoma
    K. Shigemasa
    C. Hu
    C. M. West
    J. Clarke
    G. P. Parham
    T. H. Parmley
    S. Korourian
    V. V. Baker
    T. J. O’Brien
    The Journal of the Society for Gynecologic Investigation: JSGI, 1997, 4 : 95 - 102
12345